Article info

Download PDFPDF
Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec

Authors

  1. Correspondence to M. Dominik Fischer, Centre for Ophthalmology, Universitätsklinikum Tübingen Universitäts-Augenklinik, 72076 Tübingen, Baden-Württemberg, Germany; dominik.fischer{at}uni-tuebingen.de
View Full Text

Citation

Reichel FF, Seitz I, Wozar F, et al
Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec

Publication history

  • Received December 28, 2021
  • Accepted April 17, 2022
  • First published May 24, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.